CN104640552A - 用于炎症和组织损伤的局部治疗的组合物及配制品 - Google Patents

用于炎症和组织损伤的局部治疗的组合物及配制品 Download PDF

Info

Publication number
CN104640552A
CN104640552A CN201380043623.0A CN201380043623A CN104640552A CN 104640552 A CN104640552 A CN 104640552A CN 201380043623 A CN201380043623 A CN 201380043623A CN 104640552 A CN104640552 A CN 104640552A
Authority
CN
China
Prior art keywords
treatment
composition
inflammatory
use according
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380043623.0A
Other languages
English (en)
Chinese (zh)
Inventor
卡洛·特鲁兹
鲁卡·迪格拉斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GIELLEPI SpA
Original Assignee
GIELLEPI SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GIELLEPI SpA filed Critical GIELLEPI SpA
Publication of CN104640552A publication Critical patent/CN104640552A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
CN201380043623.0A 2012-06-20 2013-06-20 用于炎症和组织损伤的局部治疗的组合物及配制品 Pending CN104640552A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2012A001076 2012-06-20
IT001076A ITMI20121076A1 (it) 2012-06-20 2012-06-20 Composizione per uso locale nel trattamento del danno tissutale
PCT/IB2013/055066 WO2013190496A2 (en) 2012-06-20 2013-06-20 Composition and formulation for topical treatment of inflammation and tissue damage

Publications (1)

Publication Number Publication Date
CN104640552A true CN104640552A (zh) 2015-05-20

Family

ID=46466706

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380043623.0A Pending CN104640552A (zh) 2012-06-20 2013-06-20 用于炎症和组织损伤的局部治疗的组合物及配制品

Country Status (8)

Country Link
US (1) US20150320838A1 (enExample)
EP (1) EP2863928A2 (enExample)
JP (1) JP2015520223A (enExample)
CN (1) CN104640552A (enExample)
IN (1) IN2015KN00091A (enExample)
IT (1) ITMI20121076A1 (enExample)
RU (1) RU2015101485A (enExample)
WO (1) WO2013190496A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101979358B1 (ko) * 2017-01-03 2019-05-15 서울대학교산학협력단 소 유방염 치료제 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1390130A (zh) * 1999-09-14 2003-01-08 阿基昂生命科学公司 用于减轻炎症的葡萄糖胺和卵

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
CN1178671C (zh) 1996-03-26 2004-12-08 Dcv公司 蛋抗炎成分、分离方法和用途
AU2372400A (en) * 1999-01-19 2000-08-07 Dcv, Inc. Egg anti-inflammatory composition and method of treating and preventing inflammation
US6706267B1 (en) * 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
AU2001260794A1 (en) * 2000-05-23 2001-12-03 N.V. Nutricia Use of egg white and egg white fractions for tissue regeneration
FR2810550B1 (fr) 2000-06-27 2004-10-08 Medibrevex Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication
RU2191551C1 (ru) 2001-07-05 2002-10-27 Волков Александр Григорьевич Способ лечения неосложненных фронтитов
JP5184726B2 (ja) * 2001-10-16 2013-04-17 帝國製薬株式会社 グルコサミン含有パップ剤
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
JP4256125B2 (ja) * 2002-08-05 2009-04-22 ロート製薬株式会社 外用組成物
US20050053564A1 (en) * 2003-09-04 2005-03-10 Chaim Lieberman Use a plant extract to enhance hair growth and hair restoration for damaged hair
US20060029657A1 (en) * 2004-03-26 2006-02-09 Stiefel Laboratories, Inc. Topical skin protectant compositions
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
EP2094277A4 (en) * 2006-10-20 2010-01-20 Kim Soo Youl COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS WITH GLUCOSAMINE AND ITS DERIVATIVES AND METHOD FOR THE TREATMENT OF ATOPIC DERMATITIS THEREWITH
JP5158436B2 (ja) * 2008-09-18 2013-03-06 国立大学法人 鹿児島大学 抗菌剤およびその製造方法、化粧料ならびに医薬品

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1390130A (zh) * 1999-09-14 2003-01-08 阿基昂生命科学公司 用于减轻炎症的葡萄糖胺和卵

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
严金林: "《推拿临证指南》", 30 September 2003, 中医古籍出版社 *
姫领会 等: "《厨房里的中医》", 31 May 2013, 中国医药科技出版社 *
杨建宇 等: "《一本书读懂偏方验方治病》", 30 April 2013, 中原农民出版社 *
祝书华: "《夏养生》", 30 May 2007, 广东经济出版社 *
自然疗法编委会: "《百病自然疗法》", 31 October 2006, 中医古籍出版社 *

Also Published As

Publication number Publication date
US20150320838A1 (en) 2015-11-12
WO2013190496A2 (en) 2013-12-27
RU2015101485A (ru) 2016-08-10
WO2013190496A3 (en) 2014-02-27
ITMI20121076A1 (it) 2013-12-21
EP2863928A2 (en) 2015-04-29
JP2015520223A (ja) 2015-07-16
IN2015KN00091A (enExample) 2015-07-31

Similar Documents

Publication Publication Date Title
Kon et al. Non-surgical management of early knee osteoarthritis
ES2456502T3 (es) Composición que comprende PNC o PNB para un preparado externo para la piel para el tratamiento de la dermatitis
WO2017011982A1 (zh) 贻贝粘蛋白产品及其抑制皮肤炎症的应用
JP2010531298A (ja) 疼痛を治療するための局所用組成物
JP5646446B2 (ja) 医療用化合物あるいは医療用製品を作成するための生体適合性ポリマーの使用方法
KR20180094915A (ko) 건선, 아토피성 피부염, 만성 두드러기, 항히스타민-내성 가려움증 및 노인성 가려움증의 치료를 위한 암보라 추출물 및 녹차 추출물을 포함하는 조성물
WO2013050959A1 (en) Composition for the treatment of skin lesions
JP2024144774A (ja) 化粧品／皮膚科用組成物
TWI495476B (zh) 用於治療肛門皸裂之組成物及其用途
CN104640552A (zh) 用于炎症和组织损伤的局部治疗的组合物及配制品
JP7410574B2 (ja) 小陰唇皮膚治療用の皮膚軟膏
CN107961232A (zh) 药物调配物和其用途
CN105727252A (zh) 一种护理组合物
CN109641001A (zh) 用于治疗缺血性溃疡和伸展疤痕的组合物
JP3652865B2 (ja) 乳酸縮合物の混合物及びそれを含有する組成物
Campisi et al. Inclusion of targeted skin products in the pre-surgical treatment regimen of peripheral lymphedema & lipedema
US20190365735A1 (en) Compositions and methods for treating varicose veins
WO2017088177A1 (zh) 贻贝粘蛋白产品及其预防和抑制神经炎症的应用
AU2023355027A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
WO2024073011A1 (en) Topical compositions and methods for the treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
KR102285956B1 (ko) 지방 생성을 자극하는 펩타이드, 조성 및 방법
Ramakrishnan et al. Role of biological membranes in the management of Stevens Johnson syndrome—Indian experience
RU2436584C1 (ru) Способ лечения дегеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических спаечных процессов
Vladimirova et al. Excesive Scar Formation After Surgical Operations And Injuries: Expirience of Early Diagnosis and Prophyilaxis
Banning Topical diclofenac: formulations for treating inflammatory pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150520

WD01 Invention patent application deemed withdrawn after publication